An Advance Healthcare Directive is a legal document that communicates a person's wishes regarding medical treatment when they are unable to make or communicate decisions due to illness, injury, or incapacity. It combines two functions that were historically separate documents: a living will (treatment instructions) and a healthcare power of attorney (agent designation). Federal law under the Patient Self-Determination Act (42 U.S.C. Sections 1395cc(f) and 1396a(w)) requires Medicare- and Medicaid-participating hospitals, nursing facilities, and home health agencies to inform patients of their right to execute advance directives and to document whether one exists.

Every state has enacted advance directive legislation, though requirements vary significantly. The Uniform Health-Care Decisions Act (UHCDA), adopted by approximately 20 states, provides a comprehensive framework covering both treatment instructions and agent designation in a single document. States that have not adopted the UHCDA maintain their own statutory forms, such as California's Advance Health Care Directive (Probate Code Sections 4700-4701), New York's Health Care Proxy (Public Health Law Article 29-C), and Texas's Directive to Physicians (Health & Safety Code Chapter 166).

The Supreme Court's decision in Cruzan v. Director, Missouri Department of Health (497 U.S. 261, 1990) established that competent individuals have a constitutionally protected liberty interest in refusing unwanted medical treatment. The Court acknowledged that states may require clear and convincing evidence of a patient's wishes before withdrawing life-sustaining treatment, which makes a properly executed advance directive the most reliable evidence of those wishes.

Every competent adult over 18 should execute an advance directive regardless of current health status. Medical emergencies occur without warning: a 35-year-old involved in a car accident, a 50-year-old who suffers a stroke, or a 28-year-old with a sudden aneurysm. Without a directive, family members may disagree about treatment, leading to court intervention as occurred in the highly publicized Terri Schiavo case in Florida.

Patients undergoing elective surgery benefit from executing or updating a directive before the procedure. Surgical complications, anesthesia reactions, or post-operative infections can result in temporary or prolonged incapacity. Hospitals routinely ask about advance directives during pre-admission processing under Patient Self-Determination Act requirements.

Individuals diagnosed with progressive conditions such as Alzheimer's disease, ALS, Parkinson's disease, or terminal cancer should execute directives while they still have decisional capacity. Capacity to execute a directive requires understanding the nature of the document, the types of decisions covered, and the consequences of the choices expressed. Once capacity is lost, the individual can no longer create or modify the directive.

Persons who are estranged from next-of-kin or whose family members hold conflicting views on end-of-life care particularly need advance directives. Without a designated agent, most state surrogate consent statutes assign decision-making authority to a spouse, then adult children, then parents, in descending order, which may not reflect the patient's actual preferences.

The healthcare agent designation must name a primary agent and at least one successor agent with full legal names, addresses, and telephone numbers. The agent's authority should be defined with specificity: the power to consent to or refuse treatment, access medical records under HIPAA (45 C.F.R. Section 164.502(g)), choose healthcare providers and facilities, authorize organ donation under the Uniform Anatomical Gift Act, and make post-death decisions regarding autopsy and disposition of remains.

Treatment instructions should address specific medical scenarios: the use of mechanical ventilation, artificial nutrition and hydration (tube feeding), CPR/resuscitation, dialysis, antibiotics for terminal infections, and blood transfusions. The directive should distinguish between situations where recovery is expected and situations involving terminal illness, permanent unconsciousness, or advanced dementia. Instructions should be medically specific rather than vague.

Pain management preferences should state whether the principal prioritizes comfort care even if pain medication may hasten death, consistent with the doctrine of double effect recognized in Vacco v. Quill (521 U.S. 793, 1997). Organ and tissue donation preferences should specify whether the principal wishes to donate, and if so, whether for transplantation, research, or both.

Execution requirements vary by state. Most states require the principal's signature, notarization, and two adult witnesses who are not the designated agent, not related to the principal, and not entitled to inherit from the principal's estate. Some states, such as New Hampshire, require only witnesses. Others, such as Missouri, require notarization. The HIPAA authorization provision should be included as a separate section authorizing the agent to access the principal's protected health information. Copies should be provided to the designated agent, primary care physician, local hospital, and family members.